Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

PP

Meet Kevin Pricing Power... (PP)

Meet Kevin Pricing Power ETF
일자:
정렬 기준:
 검색 관련기사 보기:AMEX:PP
일자시간출처헤드라인심볼기업
2008/10/1002:03Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)AMEX:PPMeet Kevin Pricing Power ETF
2008/10/0621:30MarketwiredPipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7thAMEX:PPMeet Kevin Pricing Power ETF
2008/09/1921:30MarketwiredPipex Pharmaceuticals' Oral TRIMESTA Phase IIa Clinical and Preclinical Findings Presented at World Congress on Treatment and ReAMEX:PPMeet Kevin Pricing Power ETF
2008/08/3006:01Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Amended Annual Report (Small Business Issuers) (10KSB/A)AMEX:PPMeet Kevin Pricing Power ETF
2008/08/1921:54MarketwiredPipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid ArthritisAMEX:PPMeet Kevin Pricing Power ETF
2008/08/1921:30MarketwiredPipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York CityAMEX:PPMeet Kevin Pricing Power ETF
2008/08/1505:49Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)AMEX:PPMeet Kevin Pricing Power ETF
2008/08/1505:18Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
2008/08/1502:39MarketwiredPipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 ResultsAMEX:PPMeet Kevin Pricing Power ETF
2008/08/1221:27MarketwiredPipex Pharmaceuticals to Present at the Noble Financial Equity ConferenceAMEX:PPMeet Kevin Pricing Power ETF
2008/07/1521:40Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:PPMeet Kevin Pricing Power ETF
2008/07/1507:45Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)AMEX:PPMeet Kevin Pricing Power ETF
2008/07/1003:48Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
2008/07/0921:38MarketwiredPipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of OrAMEX:PPMeet Kevin Pricing Power ETF
2008/07/0906:16Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
2008/07/0904:54MarketwiredPipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in DryAMEX:PPMeet Kevin Pricing Power ETF
2008/07/0820:41MarketwiredPipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive OfficerAMEX:PPMeet Kevin Pricing Power ETF
2008/05/2022:00MarketwiredPipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor MoleculesAMEX:PPMeet Kevin Pricing Power ETF
2008/05/1623:59Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
2008/05/1606:13Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)AMEX:PPMeet Kevin Pricing Power ETF
2008/05/1605:36MarketwiredPipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 ResultsAMEX:PPMeet Kevin Pricing Power ETF
2008/05/1322:05MarketwiredPipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15AMEX:PPMeet Kevin Pricing Power ETF
2008/05/1222:23MarketwiredPipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)AMEX:PPMeet Kevin Pricing Power ETF
2008/05/0722:00MarketwiredPipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's DiseaseAMEX:PPMeet Kevin Pricing Power ETF
2008/05/0221:38Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
2008/04/3004:35Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Proxy Statement (definitive) (DEF 14A)AMEX:PPMeet Kevin Pricing Power ETF
2008/04/2121:02MarketwiredPipex Pharmaceuticals' Oral Flupirtine Receives IND With FDA for Phase II Clinical Trial for FibromyalgiaAMEX:PPMeet Kevin Pricing Power ETF
2008/04/1906:13Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:PPMeet Kevin Pricing Power ETF
2008/04/1600:12Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)AMEX:PPMeet Kevin Pricing Power ETF
2008/04/0202:49Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
 검색 관련기사 보기:AMEX:PP